HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
OMER
Omeros Corporation
Healthcare Biotechnology · Washington, USA · Reports in usd
Market Cap: $1.35B
Market Cap
$1.35B
Enterprise Val
$1.51B
P/E Ratio
10.80
P/B Ratio
-26.26
Trailing PEG (1Y)
-0.08
As Of
Aug 19, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value-$51.3M
Gross Margin97.20%
Profit Margin97.20%
Return on Equity-109.40%
Return on Assets46.05%
Current Ratio1.95
Debt/Equity-5.78
LT Debt/Equity-4.63
Revenue Per Share0.39

Income Statement

Jun 30, 2026
Revenue$28.5M
Cost of Revenue$798.0K
Gross Profit$27.7M
R&D$13.8M
SG&A$13.9M
Operating Expenses$27.7M
Operating Income$74.0K
Interest Expense$7.6M
Tax Expense$29.0K
Net Income$13.2M
EPS (Basic)$0.18
EPS (Diluted)$0.15
EBIT$20.8M
EBITDA$21.0M
Consolidated Income$13.2M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$2.0M
Accounts Receivable$21.3M
Inventory$842.0K
Current Assets$185.2M
LT Investments$1.1M
Property, Plant & Equipment$9.7M
Intangibles$0.00
Non-Current Assets$101.6M
Total Assets$286.8M
Accounts Payable$6.3M
Current Debt$59.4M
Current Liabilities$95.0M
LT Debt$237.5M
Non-Current Liabilities$243.2M
Total Liabilities$338.2M
Total Debt$296.9M
Retained Earnings-$844.4M
Shareholder Equity-$51.3M
Shares Outstanding72,375,355

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow$4.1M
Investing Cash Flow$3.4M
Financing Cash Flow-$7.5M
CapEx-$45.0K
Free Cash Flow$4.1M
Depreciation & Amort.$193.0K
Stock-Based Comp$1.6M
Acquisitions / Disposals$0.00
Investment Activity$3.4M
Debt Issued/Repaid-$4.6M
Equity Issued/Repaid-$2.9M
Dividends Paid$0.00
Net Change in Cash$82.0K
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h